Organ | Model | Endpoint | RA_RP | IMPT_2F | IMPT_3F | P |
---|
Whole heart | RR | CHF | 1.7 ± 0.1 | 1.3 ± 0.1 | 1.3 ± 0.1 | B,C |
Left Ventricle | RR | CHF | 1.5 ± 0.1 | 1.1 ± 0.1 | 1.1 ± 0.1 | B,C |
Coronaries | RR | CAD | 1.6 ± 0.4 | 1.2 ± 0.3 | 1.2 ± 0.3 | A,B,C |
Lungs | EAR | RSCI | 19.2 ± 5.7 | 6.1 ± 2.7 | 5.7 ± 2.4 | A,B,C |
- RR Relative risk, CAD Coronay artery disease, CHF Chronic heart failure, EAR Excess absolute risk, RSCI Risk of secondary cancer inducton, RA_RP RapidArc Volumetric modulated arc therapy with RapidPlan optimization, IMPT Intensity modulated proton therapy with robust optimization (2 fields: _2F; 3 fields: _3F). Statistical significance: A: IMPT_2F vs IMPT_3F; B: IMPT_2F vs RA_RP; C: IMPT_3F vs RP_RP